Physician profile
Cullen Mccarthy
NPI 1104262112
$7,689.57
in general payments reported to CMS, 2019-2025
19 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $368 · 2021: $362 · 2022: $1,950 · 2023: $600 · 2024: $573 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,349.04 | 2019-2022 | |
| Endologix LLC | $1,798.74 | 2023-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Silk Road Medical, INC. | $1,680.04 | 2019-2022 | |
| Medtronic Vascular, INC. | $446.92 | 2019-2020 | |
| Cook Medical LLC | $298.09 | 2020-2025 | Zenith Spiral-Z |
| Penumbra, INC. | $276.62 | 2021-2025 | Penumbra System, Indigo System |
| Boston Scientific Corporation | $214.18 | 2022-2024 | |
| Kerecis Limited | $134.31 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $125.09 | 2021-2025 | Perclot |
| Abbott Laboratories | $88.27 | 2024-2025 | Diamondback Coronary, Xience Skypoint |
| Kci USA, INC. | $83.71 | 2019 | |
| Davol INC. | $45.21 | 2025 | Channel Drain |
| Becton, Dickinson and Company | $40.87 | 2024 | Progel Applicator Spray Tips |
| Veryan Medical Incorporated | $27.95 | 2023 | Biomimics 3d Vascular Stent System |
| Pfizer INC. | $21.14 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $19.81 | 2019 | |
| Lemaitre Vascular, INC. | $14.47 | 2024 | Artegraft Vascular Graft |
| Ge Healthcare | $12.72 | 2023 | |
| Janssen Pharmaceuticals, INC | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cullen Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.